Principal Financial Group Inc Fibrogen Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$0.73 - $2.73 $1,868 - $6,986	-2,559 Reduced 10.45%	21,940 $51,000
Q4 2023 Feb 07, 2024	SELL	$0.38 - $0.91 $470 - $1,125	-1,237 Reduced 4.81%	24,499 $21,000
Q3 2023 Nov 02, 2023	BUY	$0.79 - $2.83 $2,942 - $10,541	3,725 Added 16.92%	25,736 $22,000
Q2 2023 Aug 07, 2023	SELL	$2.49 - $20.59 $3,413 - $28,228	-1,371 Reduced 5.86%	22,011 $59,000
Q1 2023 May 09, 2023	SELL	$15.95 - $25.18 $14,769 - $23,316	-926 Reduced 3.81%	23,382 $436,000
Q4 2022 Feb 09, 2023	BUY	$13.27 - $17.73 $16,215 - $21,666	1,222 Added 5.29%	24,308 $389,000
Q3 2022 Nov 09, 2022	BUY	$11.4 - $14.6 $535 - $686	47 Added 0.2%	23,086 $300,000
Q2 2022 Aug 10, 2022	SELL	$7.94 - $12.96 $19,500 - $31,829	-2,456 Reduced 9.63%	23,039 $243,000
Q1 2022 May 09, 2022	BUY	$12.02 - $16.79 $5,204 - $7,270	433 Added 1.73%	25,495 $306,000
Q4 2021 Feb 09, 2022	SELL	$9.93 - $15.39 $100,809 - $156,239	-10,152 Reduced 28.83%	25,062 $353,000
Q3 2021 Nov 09, 2021	BUY	$10.18 - $26.64 $7,787 - $20,379	765 Added 2.22%	35,214 $360,000
Q2 2021 Aug 10, 2021	SELL	$18.57 - $35.68 $5.67 Million - $10.9 Million	-305,273 Reduced 89.86%	34,449 $917,000
Q1 2021 May 10, 2021	BUY	$31.0 - $55.72 $1.9 Million - $3.42 Million	61,374 Added 22.05%	339,722 $11.8 Million
Q4 2020 Feb 08, 2021	BUY	$37.09 - $48.97 $497,710 - $657,128	13,419 Added 5.07%	278,348 $10.3 Million
Q3 2020 Nov 06, 2020	BUY	$40.47 - $45.5 $103,158 - $115,979	2,549 Added 0.97%	264,929 $10.9 Million
Q2 2020 Aug 05, 2020	BUY	$32.57 - $42.83 $3.05 Million - $4.01 Million	93,649 Added 55.5%	262,380 $10.6 Million
Q1 2020 May 12, 2020	BUY	$23.3 - $45.96 $140,662 - $277,460	6,037 Added 3.71%	168,731 $5.86 Million
Q4 2019 Feb 05, 2020	SELL	$34.58 - $48.06 $80,398 - $111,739	-2,325 Reduced 1.41%	162,694 $6.98 Million
Q3 2019 Nov 13, 2019	SELL	$36.98 - $48.45 $73,220 - $95,931	-1,980 Reduced 1.19%	165,019 $6.1 Million
Q2 2019 Aug 12, 2019	BUY	$35.13 - $55.53 $847,792 - $1.34 Million	24,133 Added 16.89%	166,999 $7.55 Million
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $177,915 - $248,866	4,154 Added 2.99%	142,866 $7.77 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $481,269 - $762,528	-12,675 Reduced 8.37%	138,712 $6.42 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $213,320 - $254,810	3,789 Added 2.57%	151,387 $9.2 Million
Q2 2018 Aug 13, 2018	BUY	$44.9 - $64.95 $1.1 Million - $1.59 Million	24,423 Added 19.83%	147,598 $0
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $67,027 - $91,118	-1,478 Reduced 1.19%	123,175 $5.69 Million
Q4 2017 Feb 13, 2018	SELL	$41.95 - $60.1 $339,878 - $486,930	-8,102 Reduced 6.1%	124,653 $5.91 Million
Q3 2017 Nov 02, 2017	BUY	$33.4 - $53.9 $4.43 Million - $7.16 Million	132,755	132,755 $7.14 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account